You can legally buy Mounjaro 7.5mg online in the UK through a GPhC registered pharmacy after a clinical assessment and prescription from a UK registered prescriber. You cannot legally buy it without a prescription. If you are considering 7.5mg, you may be wondering what to expect when moving up from 5mg, whether this dose is right for you, or how to access Mounjaro safely online in the UK.
This page is for UK adults considering Mounjaro 7.5mg for weight management and looking for clear information about treatment progression, what to expect at this dose, possible side effects, pricing, eligibility, legality, and how to obtain it safely online. The 7.5mg dose is one step in the prescribed dosing schedule, so it is important to understand how dose increases work and why they should be guided by a prescriber.
If you are earlier in treatment, our Mounjaro 5mg guide covers the move up to that strength, and the 10mg guide covers the next stage of treatment.
Where 7.5mg Sits as a Maintenance Dose
Mounjaro is available in six strengths, from 2.5mg up to 15mg. The 7.5mg strength sits in the middle of the dosing range. It is not a starting dose and may be used as an intermediate step before a person moves to a higher maintenance dose.
Reaching 7.5mg generally means you have already spent time on lower strengths and your prescriber has decided that increasing the dose is appropriate. This decision can take into account how well you have tolerated your current dose, your treatment response, and your individual circumstances. Moving up is not automatic and you should not choose a higher strength yourself.
Moving From 5mg to 7.5mg: What to Expect
If your prescriber has recommended moving from 5mg to 7.5mg, it is understandable to wonder whether you will notice a difference. Everyone responds differently, but there are a few things you may experience.
Side effects may return temporarily. If nausea, constipation, indigestion, or reduced appetite had settled on 5mg, these effects may occur again after the dose is increased. For some people, these effects become less noticeable as the body adjusts, but there is no guarantee that they will settle within a particular timeframe.
You may notice changes in appetite. Some people experience a further reduction in appetite after increasing their dose, while others notice little difference. Your response can vary throughout treatment, so one person's experience should not be used to predict yours.
Weight loss does not necessarily increase in line with the dose. Moving to a higher strength does not guarantee faster weight loss. Results can vary from person to person and may change over time. Your prescriber can review your progress and decide whether your current dose remains appropriate.
Contraception advice may apply after a dose increase. UK product information advises people using oral hormonal contraception to use a barrier method or switch to a non oral contraceptive method for four weeks after starting Mounjaro and for four weeks after each dose increase. This is because Mounjaro can delay gastric emptying, which may affect the absorption of oral contraceptives. If this applies to you, speak to your healthcare professional about the most appropriate contraceptive option.
Managing the adjustment
If you notice gastrointestinal side effects after increasing your Mounjaro dose, simple measures may help you manage them. These can include eating smaller meals, avoiding foods that seem to make your symptoms worse, and drinking enough fluids.
You may also experience injection site reactions, such as redness, itching, or swelling. Follow the injection instructions provided with your medicine and rotate your injection sites between the recommended areas, such as the abdomen, thigh, or upper arm.
If side effects are severe, persistent, or worrying you, speak to your doctor, prescriber, or pharmacist. If you miss a dose, follow the instructions in the Patient Information Leaflet and the advice provided by your prescriber rather than changing your dosing schedule yourself.
How Long Do People Stay on 7.5mg?
There is no fixed amount of time that everyone should spend on 7.5mg. Your prescriber can decide whether you should remain at this strength or move to a higher dose based on your response, how well you tolerate the medicine, and your individual treatment plan.
Some people may remain on 7.5mg if their prescriber considers it appropriate. Others may move to 10mg or a higher maintenance dose if a further increase is considered suitable. The maximum maintenance dose for Mounjaro is 15mg once weekly, but reaching that dose is not necessary or appropriate for everyone.
NICE guidance (technology appraisal TA1026) also includes review points for Mounjaro treatment. If a person has not achieved sufficient weight loss after a period of treatment at the highest tolerated dose, their clinician can review whether continuing treatment remains appropriate, in line with current guidance.
Your progress should be considered as part of your overall treatment plan rather than being judged by the dose alone. Your prescriber can review your weight, response, side effects, and other relevant health factors when deciding whether to continue, adjust, or stop treatment.
Mounjaro 7.5mg Price UK
| Price | |
|---|---|
| Standard | £249.99 |
| First order with code FIRST40 | £209.99 |
| Repeat orders | £224.99 |
Each pen contains four weekly doses and covers four weeks. Bundles that include 7.5mg are also available, and live rates on the Mounjaro treatment page always take precedence.
The price includes the clinical assessment, prescription, needles and tracked delivery. Standard prescriber review is typically completed within 3 working days, express 24-hour review may be available as an optional upgrade at £24.99.
Is Mounjaro Legal in the UK?
Yes. Mounjaro (tirzepatide) is authorised by the MHRA and licensed in the UK for weight management in eligible adults and for the treatment of type 2 diabetes.
The important point is how you obtain it. Mounjaro is a prescription only medicine, which means it should only be supplied following an appropriate clinical assessment and a valid prescription from a UK registered prescriber. It should then be dispensed by a registered pharmacy.
If you are obtaining Mounjaro privately, the usual lawful route is through a private prescription issued after a clinical assessment. Be cautious of websites offering to sell Mounjaro without an assessment or prescription. Unbranded, counterfeit, or "research" versions sold outside the licensed supply chain should not be used.
The six strengths, including 7.5mg, are covered by the same UK authorisation. There is no separate legal status for the individual strengths. The appropriate strength depends on where you are in treatment and what your prescriber considers suitable for you.
How to Get Mounjaro in the UK
There are two legitimate routes to access Mounjaro in the UK.
Privately, you can use a GPhC registered pharmacy that provides access to a UK registered prescriber. You will normally need to complete a clinical consultation before a prescriber assesses whether Mounjaro is suitable for you. If it is prescribed, the pharmacy can dispense the medicine and arrange delivery where this service is available.
Through the NHS, if you meet the relevant eligibility criteria. NHS access to tirzepatide is being introduced in phases following NICE guidance, with eligibility and implementation depending on the current national guidance and local arrangements. NHS eligibility is narrower than the full licensed use of Mounjaro for weight management, so being eligible to use Mounjaro under its licence does not automatically mean that you qualify for NHS treatment.
In either case, the prescribing decision and the strength you receive should be based on a clinical assessment. You should not select a dose simply because it is available to order.
A note on who prescribes
You may see information suggesting that Mounjaro prescriptions must come from a doctor. In the UK, prescriptions can also be issued by suitably qualified pharmacist independent prescribers, provided they are appropriately registered and working within their professional scope.
The important point is that the prescriber is appropriately registered, carries out a suitable clinical assessment, and prescribes Mounjaro when it is considered appropriate for the individual patient.
Eligibility
For weight management, the licensed use of Mounjaro generally covers adults with obesity, or adults who are overweight and have at least one weight related health condition, subject to the full licensed criteria and an individual clinical assessment.
Examples of weight related health conditions can include high blood pressure, abnormal blood lipid levels, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes.
NHS eligibility criteria are more restrictive than the full licensed criteria and are being introduced in stages. The criteria can also depend on current national guidance and local NHS arrangements.
Mounjaro may not be suitable for everyone. For example, it should not be used during pregnancy, and additional considerations apply if you are breastfeeding or trying to conceive. Your prescriber will also consider your medical history, including conditions such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, previous pancreatitis, or certain digestive conditions.
Treatment suitability and the strength prescribed depend on an individual clinical assessment. Our guide to prescription weight loss treatments covers the wider options.
Safety and Reporting
Mounjaro is subject to ongoing safety monitoring in the UK. If you experience a suspected side effect, you can report it through the MHRA Yellow Card scheme. You can also discuss side effects with your prescriber, pharmacist, or GP.
Contact your prescriber, GP, or NHS 111 if you develop severe or persistent abdominal pain, persistent vomiting, signs of dehydration, symptoms of low blood sugar, or another symptom that concerns you. The risk of low blood sugar can be higher when Mounjaro is used with certain diabetes medicines, such as insulin or sulfonylureas.
Serious side effects can occur, including pancreatitis and gallbladder problems. Seek urgent medical attention if you develop symptoms of a severe allergic reaction.
For a medical emergency, call 999. For full information about side effects, storage, warnings, and how to use Mounjaro, read the Patient Information Leaflet supplied with your medicine and speak to your healthcare professional if you have questions.
Key Takeaways
- 7.5mg is a mid titration strength and should only be prescribed when your prescriber considers it appropriate.
- Side effects such as nausea, constipation, or indigestion may occur again after a dose increase, although this varies from person to person.
- A higher strength does not guarantee faster or greater weight loss.
- If you use oral hormonal contraception, contraception advice applies again for four weeks after each Mounjaro dose increase.
- 7.5mg is £209.99 on a first order, £224.99 on repeats, and £249.99 standard.
- Mounjaro is MHRA authorised in the UK, but it is a prescription only medicine.
- Mounjaro prescriptions can be issued by appropriately registered prescribers, including suitably qualified pharmacist independent prescribers, and are not limited to doctors.
